Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19
Fen Zhang, Yating Wan, Tao Zuo, et al.
Gastroenterology (2021) Vol. 162, Iss. 2, pp. 548-561.e4
Open Access | Times Cited: 198

Showing 1-25 of 198 citing articles:

Short-chain fatty acids: linking diet, the microbiome and immunity
Elizabeth R. Mann, Ying Ka Lam, Holm H. Uhlig
Nature reviews. Immunology (2024) Vol. 24, Iss. 8, pp. 577-595
Closed Access | Times Cited: 239
Short-chain fatty acids in diseases
Dan Zhang, Yong‐Ping Jian, Yuning Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 196
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 188
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
Bin Wang, Lei Zhang, Yongqiang Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 159
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia
Lucie Bernard, Mericien Venzon, Jon Klein, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 137
Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications
Naoyoshi Nagata, Tadashi Takeuchi, Hiroaki Masuoka, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 272-288
Open Access | Times Cited: 100
Gut microbiota: A new insight into lung diseases
Peijun Ma, Mengmeng Wang, Yun Wang
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113810-113810
Open Access | Times Cited: 84
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 400-400
Open Access | Times Cited: 81
What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?
Monika Gudowska-Sawczuk, Barbara Mroczko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3673-3673
Open Access | Times Cited: 76
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 70
A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
Raphaela Iris Lau, Qi Su, I.S. Lau, et al.
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 3, pp. 256-265
Open Access | Times Cited: 52
Akkermansia muciniphila protects the intestine from irradiation-induced injury by secretion of propionic acid
Kai-Yue He, Xin‐Yuan Lei, Dan‐Hui Wu, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 44
The gut–airway microbiome axis in health and respiratory diseases
Mustafa Özçam, Susan V. Lynch
Nature Reviews Microbiology (2024) Vol. 22, Iss. 8, pp. 492-506
Closed Access | Times Cited: 27
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
Ziqi Ma, Tao Zuo, Norbert Frey, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Gut feelings on short-chain fatty acids to regulate respiratory health
Samantha N. Rowland, Christopher G. Green, John R. Halliwill, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 2
Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases
Sumel Ashique, Gabriele De Rubis, Ekta Sirohi, et al.
Chemico-Biological Interactions (2022) Vol. 368, pp. 110231-110231
Closed Access | Times Cited: 61
Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome
Qin Liu, Qi Su, Fen Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection
Lorenza Romani, Federica Del Chierico, Gabriele Macari, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 49
Microbiota and COVID-19: Long-term and complex influencing factors
Jiaqi Gang, Haiyu Wang, Xiangsheng Xue, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 47
Gastrointestinal symptoms in COVID-19: the long and the short of it
Daniel E. Freedberg, Lin Chang
Current Opinion in Gastroenterology (2022)
Closed Access | Times Cited: 44
Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes
Shanlin Ke, Scott T. Weiss, Yang‐Yu Liu
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Fecal microbiota transplantation and short-chain fatty acids reduce sepsis mortality by remodeling antibiotic-induced gut microbiota disturbances
Xiran Lou, Jinfang Xue, Ruifei Shao, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 39
Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms
Viviani Mendes de Almeida, Daiane F. Engel, Mayra Fernanda Ricci, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 38
Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein–Barr virus and the gut–brain axis
Kenji Hashimoto
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 4968-4976
Open Access | Times Cited: 35
Akkermansia muciniphila attenuated lipopolysaccharide-induced acute lung injury by modulating the gut microbiota and SCFAs in mice
Jian Shen, Shuting Wang, Xia He, et al.
Food & Function (2023) Vol. 14, Iss. 23, pp. 10401-10417
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top